Home | About PR | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |   Login 
Pharmacognosy Magazine
Search Article 
Advanced search 
This article has been cited by
1Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges
Attila Oláh,Zoltán Szekanecz,Tamás Bíró
Frontiers in Immunology.2017;8()
2Canadian Association of Gastroenterology Position Statement: Use of Cannabis in Gastroenterological and Hepatic Disorders
Christopher N Andrews,Shane M Devlin,Bernard Le Foll,Benedikt Fischer,Frances Tse,Martin Storr,Stephen E Congly
Journal of the Canadian Association of Gastroenterology.2019;2(1)37
3Cannabidiol for Viral Diseases: Hype or Hope?
Alex Mabou Tagne,Barbara Pacchetti,Mikael Sodergren,Marco Cosentino,Franca Marino
Cannabis and Cannabinoid Research.2020;5(2)121
4Reduced Incidence and Better Liver Disease Outcomes among Chronic HCV Infected Patients Who Consume Cannabis
Adeyinka Charles Adejumo,Oluwole Muyiwa Adegbala,Kelechi Lauretta Adejumo,Terence Ndonyi Bukong
Canadian Journal of Gastroenterology and Hepatology.2018;2018(2)1
5Use of cannabis and risk of advanced liver fibrosis in patients with chronic hepatitis C virus infection: A systematic review and meta-analysis
Karn Wijarnpreecha,Panadeekarn Panjawatanan,Patompong Ungprasert
Journal of Evidence-Based Medicine.2018;11(4)272
6The potential of cannabidiol in the COVID-19 pandemic
Giuseppe Esposito,Marcella Pesce,Luisa Seguella,Walter Sanseverino,Jie Lu,Chiara Corpetti,Giovanni Sarnelli
British Journal of Pharmacology.2020;177(21)4967
7Cannabinoids and the Coronavirus
Kevin P. Hill
Cannabis and Cannabinoid Research.2020;5(2)118
8Analysis of natural product regulation of opioid receptors in the treatment of human disease
S. Badal,S. Turfus,R. Rajnarayanan,C. Wilson-Clarke,S.L. Sandiford
Pharmacology & Therapeutics.2018;184(2)51